In comparison to the other types of breast cancer subtypes, TNBC exhibits a higher ability of infiltration of the immune cells and an elevated tendency for immune checkpoint molecule expression, including cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed death-ligand 1 (PD-L1) [17]. This evidence concerns the gene CTLA4 and breast carcinoma.